Transcranial photobiomodulation in children aged 2–6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology
BackgroundSmall pilot studies have suggested that transcranial photobiomodulation (tPBM) could help reduce symptoms of neurological conditions, such as depression, traumatic brain injury, and autism spectrum disorder (ASD).ObjectiveTo examine the impact of tPBM on the symptoms of ASD in children age...
Tallennettuna:
| Päätekijät: | , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2024-04-01
|
| Sarja: | Frontiers in Neurology |
| Aiheet: | |
| Linkit: | https://www.frontiersin.org/articles/10.3389/fneur.2024.1221193/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|